(Q35897124)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

toxic epidermal necrolysis

2 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Thong BY

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Tan AW

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Khin LW

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Chng HH

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Heng WJ

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

846-853

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389280%20AND%20SRC:MED&resulttype=core&format=json

Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Pathogenesis of drug-induced exanthems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

A review of toxic epidermal necrolysis in Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Sjögren-like syndrome after drug-induced toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Intravenous immunoglobulins in the treatment of severe drug eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

7 January 2021

Ocular Aftermath of Stevens-Johnson Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

7 January 2021

Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

7 January 2021

Treatment of toxic epidermal necrolysis with cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

7 January 2021

Severe bullous drug reactions treated successfully with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

7 January 2021

Plasma exchange in patients with toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

7 January 2021

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701653

7 January 2021